Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load

Leishmaniasis is a neglected disease, for which current treatment presents numerous issues. Leishmania amazonensis is the etiological agent of cutaneous and diffuse cutaneous leishmaniasis. The roles of the programmed death-1 (PD-1) receptor on lymphocytes and its ligand (PD-L1) on antigen-presentin...

Descripción completa

Detalles Bibliográficos
Autores principales: da Fonseca-Martins, Alessandra M., Ramos, Tadeu D., Pratti, Juliana E. S., Firmino-Cruz, Luan, Gomes, Daniel Claudio Oliveira, Soong, Lynn, Saraiva, Elvira M., de Matos Guedes, Herbert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937231/
https://www.ncbi.nlm.nih.gov/pubmed/31889072
http://dx.doi.org/10.1038/s41598-019-56336-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937231/
https://www.ncbi.nlm.nih.gov/pubmed/31889072
http://dx.doi.org/10.1038/s41598-019-56336-8

Ejemplares similares